Clinical Trial Update: DOXIL for Consolidation Therapy in Ovarian Cancer. [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results for DOXIL as consolidation therapy in ovarian cancer, with the study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)

Snippet

Sponsor: Southeastern Gynecologic Oncology | Conditions: Ovarian Neoplasm | Phase 2 | Status: COMPLETED